Andrew P. Han

Though the funding is technically there, doctors may not be comfortable ordering the test and hospitals may wonder if they'll lose money from it.

The firm also spoke about the need to interact with the FDA to clarify how to get its SomaSignal assay for cardiovascular events into clinical trials.

The so-called Max Read flow cell could accommodate up to 1 billion reads, lowering costs for applications that require sequence reads shorter than 100 bp.

The firm has filed patent infringement lawsuits against NanoString in Germany and Vizgen in the US, according to a document filed last week with SEC.

The jury also invalidated three Illumina patents that the firm had accused MGI Tech and BGI of infringing in a countersuit. Illumina said it will appeal the verdict.

The company has also instituted its yearly "typical price increase" on some products, including NGS and library prep reagents, company officials explained.

Invitae will no longer make payments during the R&D phase of the collaboration and instead will pay a higher price on the instrument and consumables later on.

The company was forced to replace some assay kits shipped to Europe that spoiled after falling out of required refrigerated temperature ranges.

The Watertown, Massachusetts-based firm is looking to develop T cell-based therapies in China, among other applications.

Pacific Biosciences' HiFi sequencing protocol now includes 5mC methylation calls for every genome. What will researchers discover with it?